Back to Search Start Over

B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.

Authors :
Wang SS
Vajdic CM
Linet MS
Slager SL
Voutsinas J
Nieters A
Casabonne D
Cerhan JR
Cozen W
Alarcón G
Martínez-Maza O
Brown EE
Bracci PM
Turner J
Hjalgrim H
Bhatti P
Zhang Y
Birmann BM
Flowers CR
Paltiel O
Holly EA
Kane E
Weisenburger DD
Maynadié M
Cocco P
Foretova L
Breen EC
Lan Q
Brooks-Wilson A
De Roos AJ
Smith MT
Roman E
Boffetta P
Kricker A
Zheng T
Skibola CF
Clavel J
Monnereau A
Chanock SJ
Rothman N
Benavente Y
Hartge P
Smedby KE
Source :
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2022 May 04; Vol. 31 (5), pp. 1103-1110.
Publication Year :
2022

Abstract

Background: A previous International Lymphoma Epidemiology (InterLymph) Consortium evaluation of joint associations between five immune gene variants and autoimmune conditions reported interactions between B-cell response-mediated autoimmune conditions and the rs1800629 genotype on risk of B-cell non-Hodgkin lymphoma (NHL) subtypes. Here, we extend that evaluation using NHL subtype-specific polygenic risk scores (PRS) constructed from loci identified in genome-wide association studies of three common B-cell NHL subtypes.<br />Methods: In a pooled analysis of NHL cases and controls of Caucasian descent from 14 participating InterLymph studies, we evaluated joint associations between B-cell-mediated autoimmune conditions and tertile (T) of PRS for risk of diffuse large B-cell lymphoma (DLBCL; n = 1,914), follicular lymphoma (n = 1,733), and marginal zone lymphoma (MZL; n = 407), using unconditional logistic regression.<br />Results: We demonstrated a positive association of DLBCL PRS with DLBCL risk [T2 vs. T1: OR = 1.24; 95% confidence interval (CI), 1.08-1.43; T3 vs. T1: OR = 1.81; 95% CI, 1.59-2.07; P-trend (Ptrend) < 0.0001]. DLBCL risk also increased with increasing PRS tertile among those with an autoimmune condition, being highest for those with a B-cell-mediated autoimmune condition and a T3 PRS [OR = 6.46 vs. no autoimmune condition and a T1 PRS, Ptrend < 0.0001, P-interaction (Pinteraction) = 0.49]. Follicular lymphoma and MZL risk demonstrated no evidence of joint associations or significant Pinteraction.<br />Conclusions: Our results suggest that PRS constructed from currently known subtype-specific loci may not necessarily capture biological pathways shared with autoimmune conditions.<br />Impact: Targeted genetic (PRS) screening among population subsets with autoimmune conditions may offer opportunities for identifying those at highest risk for (and early detection from) DLBCL.<br /> (©2022 The Authors; Published by the American Association for Cancer Research.)

Details

Language :
English
ISSN :
1538-7755
Volume :
31
Issue :
5
Database :
MEDLINE
Journal :
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Publication Type :
Academic Journal
Accession number :
35244686
Full Text :
https://doi.org/10.1158/1055-9965.EPI-21-0875